BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

258 related articles for article (PubMed ID: 24107468)

  • 41. Reduced levels of hydroxylated, polyunsaturated ultra long-chain fatty acids in the serum of colorectal cancer patients: implications for early screening and detection.
    Ritchie SA; Ahiahonu PW; Jayasinghe D; Heath D; Liu J; Lu Y; Jin W; Kavianpour A; Yamazaki Y; Khan AM; Hossain M; Su-Myat KK; Wood PL; Krenitsky K; Takemasa I; Miyake M; Sekimoto M; Monden M; Matsubara H; Nomura F; Goodenowe DB
    BMC Med; 2010 Feb; 8():13. PubMed ID: 20156336
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Serum Expression of
    Li S; Huang M; Liu Q; Wang D; Wu R; Zhang X; Chen W; Duan L
    Dis Markers; 2019; 2019():5070524. PubMed ID: 31781302
    [TBL] [Abstract][Full Text] [Related]  

  • 43. A plasma microRNA panel for early detection of colorectal cancer.
    Wang S; Xiang J; Li Z; Lu S; Hu J; Gao X; Yu L; Wang L; Wang J; Wu Y; Chen Z; Zhu H
    Int J Cancer; 2015 Jan; 136(1):152-61. PubMed ID: 23456911
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Role of serum Metadherin mRNA expression in the diagnosis and prediction of survival in patients with colorectal cancer.
    Abdel Ghafar MT; Gharib F; Abdel-Salam S; Elkhouly RA; Elshora A; Shalaby KH; El-Guindy D; El-Rashidy MA; Soliman NA; Abu-Elenin MM; Allam AA
    Mol Biol Rep; 2020 Apr; 47(4):2509-2519. PubMed ID: 32088817
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Prospective evaluation of 64 serum autoantibodies as biomarkers for early detection of colorectal cancer in a true screening setting.
    Chen H; Werner S; Butt J; Zörnig I; Knebel P; Michel A; Eichmüller SB; Jäger D; Waterboer T; Pawlita M; Brenner H
    Oncotarget; 2016 Mar; 7(13):16420-32. PubMed ID: 26909861
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Clinically Applicable Serum Biomarkers Among 14 Candidates Associated With Recurrence of Stage II and III Colorectal Cancer.
    Kim CW; Ha YJ; Tak KH; Roh SA; Kim SK; Kim SY; Kim YS; Cho DH; Kim JC
    Anticancer Res; 2021 Sep; 41(9):4651-4658. PubMed ID: 34475094
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Quantitation of putative colorectal cancer biomarker candidates in serum extracellular vesicles by targeted proteomics.
    Shiromizu T; Kume H; Ishida M; Adachi J; Kano M; Matsubara H; Tomonaga T
    Sci Rep; 2017 Oct; 7(1):12782. PubMed ID: 28986585
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Combination of preoperative NLR, PLR and CEA could increase the diagnostic efficacy for I-III stage CRC.
    Peng HX; Yang L; He BS; Pan YQ; Ying HQ; Sun HL; Lin K; Hu XX; Xu T; Wang SK
    J Clin Lab Anal; 2017 Sep; 31(5):. PubMed ID: 27686880
    [TBL] [Abstract][Full Text] [Related]  

  • 49. UHPLC-HRMS-based Multiomics to Explore the Potential Mechanisms and Biomarkers for Colorectal Cancer.
    Wang X; Guan X; Tong Y; Liang Y; Huang Z; Wen M; Luo J; Chen H; Yang S; She Z; Wei Z; Zhou Y; Qi Y; Zhu P; Nong Y; Zhang Q
    BMC Cancer; 2024 May; 24(1):644. PubMed ID: 38802800
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Serum netrin-1 as a biomarker for colorectal cancer detection.
    Li B; Shen K; Zhang J; Jiang Y; Yang T; Sun X; Ma X; Zhu J
    Cancer Biomark; 2020; 28(3):391-396. PubMed ID: 32474463
    [TBL] [Abstract][Full Text] [Related]  

  • 51. A case-control study of pre-operative levels of serum neutrophil gelatinase-associated lipocalin and other potential inflammatory markers in colorectal cancer.
    Duvillard L; Ortega-Deballon P; Bourredjem A; Scherrer ML; Mantion G; Delhorme JB; Deguelte-Lardière S; Petit JM; Bonithon-Kopp C;
    BMC Cancer; 2014 Dec; 14():912. PubMed ID: 25472811
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Blood-derived molecular signatures as biomarker panels for the early detection of colorectal cancer.
    Gan X; Wang T; Chen ZY; Zhang KH
    Mol Biol Rep; 2020 Oct; 47(10):8159-8168. PubMed ID: 32979165
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Multi-dimensional fragmentomic assay for ultrasensitive early detection of colorectal advanced adenoma and adenocarcinoma.
    Ma X; Chen Y; Tang W; Bao H; Mo S; Liu R; Wu S; Bao H; Li Y; Zhang L; Wu X; Cai S; Shao Y; Liu F; Peng J
    J Hematol Oncol; 2021 Oct; 14(1):175. PubMed ID: 34702327
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Applying simple linear combination, multiple logistic and factor analysis methods for candidate fecal bacteria as novel biomarkers for early detection of adenomatous polyps and colon cancer.
    Rezasoltani S; Sharafkhah M; Asadzadeh Aghdaei H; Nazemalhosseini Mojarad E; Dabiri H; Akhavan Sepahi A; Modarressi MH; Feizabadi MM; Zali MR
    J Microbiol Methods; 2018 Dec; 155():82-88. PubMed ID: 30439465
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Identification and evaluation of plasma microRNAs for early detection of colorectal cancer.
    Luo X; Stock C; Burwinkel B; Brenner H
    PLoS One; 2013; 8(5):e62880. PubMed ID: 23690963
    [TBL] [Abstract][Full Text] [Related]  

  • 56. A Plasma-Based Protein Marker Panel for Colorectal Cancer Detection Identified by Multiplex Targeted Mass Spectrometry.
    Jones JJ; Wilcox BE; Benz RW; Babbar N; Boragine G; Burrell T; Christie EB; Croner LJ; Cun P; Dillon R; Kairs SN; Kao A; Preston R; Schreckengaust SR; Skor H; Smith WF; You J; Hillis WD; Agus DB; Blume JE
    Clin Colorectal Cancer; 2016 Jun; 15(2):186-194.e13. PubMed ID: 27237338
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Alu-based cell-free DNA: a potential complementary biomarker for diagnosis of colorectal cancer.
    Qi J; Qian C; Shi W; Wu X; Jing R; Zhang L; Wang Z; Ju S
    Clin Biochem; 2013 Jan; 46(1-2):64-9. PubMed ID: 22975639
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Biomarker measurement in non-invasively sampled colorectal mucus as a novel approach to colorectal cancer detection: screening and triage implications.
    Loktionov A; Soubieres A; Bandaletova T; Francis N; Allison J; Sturt J; Mathur J; Poullis A
    Br J Cancer; 2020 Jul; 123(2):252-260. PubMed ID: 32398859
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Quantitative proteomic analysis exploring progression of colorectal cancer: Modulation of the serpin family.
    Peltier J; Roperch JP; Audebert S; Borg JP; Camoin L
    J Proteomics; 2016 Oct; 148():139-48. PubMed ID: 27492143
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Biomarker discovery study of inflammatory proteins for colorectal cancer early detection demonstrated importance of screening setting validation.
    Qian J; Tikk K; Werner S; Balavarca Y; Saadati M; Hechtner M; Brenner H
    J Clin Epidemiol; 2018 Dec; 104():24-34. PubMed ID: 30076979
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 13.